{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:10Z","timestamp":1792723090314,"version":"4.5.0"},"reference-count":180,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neurot.2026.e01036","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:23:44Z","timestamp":1786022624000},"page":"e01036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extracellular vesicles: Navigating new frontiers in glioblastoma therapy"],"prefix":"10.1016","volume":"23","author":[{"given":"Natalia Claire","family":"Mendonca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longsha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok-Siong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e01036_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.wneu.2018.04.022","article-title":"Challenges in the treatment of glioblastoma: multisystem mechanisms of therapeutic resistance","volume":"116","author":"Noch","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.neurot.2026.e01036_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108352","article-title":"Extracellular vesicle-based therapeutics: extracellular vesicles as therapeutic targets and agents","volume":"242","author":"Takahashi","year":"2023","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Thery","year":"2018","journal-title":"J Extracell Vesicles"},{"issue":"Pt 2","key":"10.1016\/j.neurot.2026.e01036_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.semcancer.2022.06.001","article-title":"Extracellular vesicles in cancer therapy","volume":"86","author":"Wang","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01036_bib5","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1172\/JCI81134","article-title":"Extracellular vesicles and intercellular communication within the nervous system","volume":"126","author":"Zappulli","year":"2016","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01036_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","article-title":"Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake","volume":"36","author":"Abels","year":"2016","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.neurot.2026.e01036_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fonc.2019.00125","article-title":"Intercellular vesicular transfer by exosomes, microparticles and oncosomes - implications for cancer biology and treatments","volume":"9","author":"Jaiswal","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.neurot.2026.e01036_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcdb.2015.02.010","article-title":"Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes","volume":"40","author":"Minciacchi","year":"2015","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010096","article-title":"Extracellular vesicle-mediated communication between the glioblastoma and its microenvironment","volume":"9","author":"Matarredona","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01036_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"22","key":"10.1016\/j.neurot.2026.e01036_bib11","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.cub.2009.09.059","article-title":"ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles","volume":"19","author":"Muralidharan-Chari","year":"2009","journal-title":"Curr Biol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01036_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/21541248.2016.1215283","article-title":"Biology and biogenesis of shed microvesicles","volume":"8","author":"Tricarico","year":"2017","journal-title":"Small GTPases"},{"issue":"13","key":"10.1016\/j.neurot.2026.e01036_bib13","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1158\/0008-5472.CAN-08-3860","article-title":"Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease","volume":"69","author":"Di Vizio","year":"2009","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01036_bib14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/emmm.201200242","article-title":"DIAPH3 governs the cellular transition to the amoeboid tumour phenotype","volume":"4","author":"Hager","year":"2012","journal-title":"EMBO Mol Med"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01036_bib15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ajpath.2012.07.030","article-title":"Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease","volume":"181","author":"Di Vizio","year":"2012","journal-title":"Am J Pathol"},{"issue":"13","key":"10.1016\/j.neurot.2026.e01036_bib16","doi-asserted-by":"crossref","first-page":"11327","DOI":"10.18632\/oncotarget.3598","article-title":"Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles","volume":"6","author":"Minciacchi","year":"2015","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.neurot.2026.e01036_bib17","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.4161\/cc.26539","article-title":"Large oncosomes mediate intercellular transfer of functional microRNA","volume":"12","author":"Morello","year":"2013","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01036_bib18","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1158\/0008-5472.CAN-16-2942","article-title":"MYC mediates large oncosome-induced fibroblast reprogramming in prostate cancer","volume":"77","author":"Minciacchi","year":"2017","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01036_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncb1725","article-title":"Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells","volume":"10","author":"Al-Nedawi","year":"2008","journal-title":"Nat Cell Biol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01036_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","article-title":"Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics","volume":"16","author":"Rennick","year":"2021","journal-title":"Nat Nanotechnol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01036_bib22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01036_bib23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.183.3.1161","article-title":"B lymphocytes secrete antigen-presenting vesicles","volume":"183","author":"Raposo","year":"1996","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01036_bib24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1096\/fj.03-1094fje","article-title":"Adhesion and signaling by B cell-derived exosomes: the role of integrins","volume":"18","author":"Clayton","year":"2004","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1627164","article-title":"Brainwashed by extracellular vesicles: the role of extracellular vesicles in primary and metastatic brain tumour microenvironment","volume":"8","author":"Morad","year":"2019","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.neurot.2026.e01036_bib26","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.24641","article-title":"Routes and mechanisms of extracellular vesicle uptake","volume":"3","author":"Mulcahy","year":"2014","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01036_bib27","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.bbadis.2017.02.023","article-title":"Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis","volume":"1863","author":"Wang","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01036_bib28","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1159\/000438594","article-title":"Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation","volume":"37","author":"Teng","year":"2015","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01036_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12133","article-title":"Extracellular vesicles from in vivo liver tissue accelerate recovery of liver necrosis induced by carbon tetrachloride","volume":"10","author":"Lee","year":"2021","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12951-024-02790-0","article-title":"Hepatocyte-derived tissue extracellular vesicles safeguard liver regeneration and support regenerative therapy","volume":"22","author":"Ying","year":"2024","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/HYPERTENSIONAHA.121.14596","article-title":"Mesenchymal Stem\/Stromal cell-derived extracellular vesicles for chronic kidney disease: are we there yet?","volume":"78","author":"Eirin","year":"2021","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01036_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126596","article-title":"Mesenchymal stem cell-derived extracellular vesicles to the rescue of renal injury","volume":"22","author":"Birtwistle","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01036_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071911","article-title":"Clinical prospect of mesenchymal Stromal\/Stem cell-derived extracellular vesicles in kidney disease: challenges and the way forward","volume":"15","author":"Kosanovic","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neurot.2026.e01036_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40824-016-0068-0","article-title":"Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases","volume":"20","author":"Nassar","year":"2016","journal-title":"Biomater Res"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01036_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ph14080811","article-title":"Extracellular vesicles in skin wound healing","volume":"14","author":"Narauskaite","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01036_bib36","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/med.21918","article-title":"Extracellular vesicles: emerging frontiers in wound healing","volume":"42","author":"Hade","year":"2022","journal-title":"Med Res Rev"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01036_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044104","article-title":"Extracellular vesicle-based hydrogels for wound healing applications","volume":"24","author":"Amengual-Tugores","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2026.e01036_bib38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.addr.2018.01.018","article-title":"Extracellular vesicles as modulators of wound healing","volume":"129","author":"Cabral","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01036_bib39","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1007\/s13346-023-01328-5","article-title":"Tumour-derived extracellular vesicle based vaccines for melanoma treatment","volume":"13","author":"Gonzalez-Melero","year":"2023","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1779991","article-title":"Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy","volume":"9","author":"Naseri","year":"2020","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/neuonc\/nov244","article-title":"Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia\/macrophages in the brain","volume":"18","author":"van der Vos","year":"2016","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01036_bib42","first-page":"945","article-title":"TGF-beta signaling and its targeting for glioma treatment","volume":"5","author":"Han","year":"2015","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.neurot.2026.e01036_bib43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.vph.2016.03.005","article-title":"Extracellular vesicles as new players in angiogenesis","volume":"86","author":"Kholia","year":"2016","journal-title":"Vasc Pharmacol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01036_bib44","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/ijc.29521","article-title":"Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells","volume":"137","author":"de Vrij","year":"2015","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11060-016-2298-3","article-title":"Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease","volume":"131","author":"Mallawaaratchy","year":"2017","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.neurot.2026.e01036_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biochi.2018.02.007","article-title":"Temozolomide affects extracellular vesicles released by glioblastoma cells","volume":"155","author":"Andre-Gregoire","year":"2018","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1078-0432.CCR-18-1941","article-title":"Clinical significance of extracellular vesicles in plasma from glioblastoma patients","volume":"25","author":"Osti","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neurot.2026.e01036_bib48","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fonc.2019.00651","article-title":"Isolation and analysis of plasma-derived exosomes in patients with glioma","volume":"9","author":"Cumba Garcia","year":"2019","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01036_bib49","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/nm.2994","article-title":"Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy","volume":"18","author":"Shao","year":"2012","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01036_bib50","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ncb1800","article-title":"Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers","volume":"10","author":"Skog","year":"2008","journal-title":"Nat Cell Biol"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01036_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105214","article-title":"MicroRNAs and extracellular vesicles as distinctive biomarkers of precocious and advanced stages of breast cancer brain metastases development","volume":"22","author":"Figueira","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2026.e01036_bib52","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1038\/ncomms7716","article-title":"Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier","volume":"6","author":"Tominaga","year":"2015","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01036_bib53","first-page":"205","article-title":"Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes","volume":"3","author":"Hao","year":"2006","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib54","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41467-018-02865-1","article-title":"Activated CD8(+) T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells","volume":"9","author":"Seo","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib55","article-title":"IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8(+) T cells","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e01036_bib56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ncomms1285","article-title":"Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells","volume":"2","author":"Mittelbrunn","year":"2011","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/j.neurot.2026.e01036_bib57","article-title":"CD4(+) T cell-released extracellular vesicles potentiate the efficacy of the HBsAg vaccine by enhancing B cell responses","volume":"6","author":"Lu","year":"2019","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.neurot.2026.e01036_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.blre.2018.11.002","article-title":"Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management","volume":"34","author":"Brudno","year":"2019","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib59","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1038\/s41467-019-12321-3","article-title":"CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity","volume":"10","author":"Fu","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/MN:30:2:157","article-title":"Brain endothelial cells as pharmacological targets in brain tumors","volume":"30","author":"Demeule","year":"2004","journal-title":"Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01036_bib61","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01036_bib62","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/term.3244","article-title":"Brain endothelial cells-derived extracellular vesicles overexpressing ECRG4 inhibit glioma proliferation through suppressing inflammation and angiogenesis","volume":"15","author":"Huo","year":"2021","journal-title":"J Tissue Eng Regen Med"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01036_bib63","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.biotechadv.2012.08.008","article-title":"Exosomes for drug delivery - a novel application for the mesenchymal stem cell","volume":"31","author":"Lai","year":"2013","journal-title":"Biotechnol Adv"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib64","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-021-01141-y","article-title":"Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer","volume":"14","author":"Weng","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.neurot.2026.e01036_bib65","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3389\/fonc.2020.01453","article-title":"The antitumor effect of gene-engineered exosomes in the treatment of brain metastasis of breast cancer","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol"},{"issue":"20","key":"10.1016\/j.neurot.2026.e01036_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011187","article-title":"Application of mesenchymal stem cells in targeted delivery to the brain: potential and challenges of the extracellular vesicle-based approach for brain tumor treatment","volume":"22","author":"Do","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"Suppl 2","key":"10.1016\/j.neurot.2026.e01036_bib67","first-page":"S79","article-title":"Clinical pharmacology considerations on recombinant adeno-associated virus-based gene therapy","volume":"62","author":"Sun","year":"2022","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s43141-023-00518-5","article-title":"Biophysical characterization of adeno-associated virus capsid through the viral transduction life cycle","volume":"21","author":"Xiang","year":"2023","journal-title":"J Genet Eng Biotechnol"},{"key":"10.1016\/j.neurot.2026.e01036_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2026.e01036_bib70","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.omtm.2021.06.015","article-title":"ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia","volume":"22","author":"Ilyinskii","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01036_bib71","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1016\/j.jtha.2024.07.012","article-title":"Adeno-associated viral vector integration: implications for long-term efficacy and safety","volume":"22","author":"Batty","year":"2024","journal-title":"J Thromb Haemostasis"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01036_bib72","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.ymthe.2022.06.004","article-title":"Evaluating the state of the science for adeno-associated virus integration: an integrated perspective","volume":"30","author":"Sabatino","year":"2022","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01036_bib73","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/mt.2011.289","article-title":"Retroviral integrations in gene therapy trials","volume":"20","author":"Biasco","year":"2012","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01036_bib74","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41434-021-00278-2","article-title":"Characterization of integration frequency and insertion sites of adenovirus DNA into mouse liver genomic DNA following intravenous injection","volume":"29","author":"Wang","year":"2022","journal-title":"Gene Ther"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib75","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/17435889.2025.2587715","article-title":"Advancing RNA delivery with Ionizable lipid nanoparticles: the roles of microfluidics and machine learning","volume":"21","author":"Rostami","year":"2026","journal-title":"Nanomedicine (N Y, NY, U S)"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41597-025-06456-w","article-title":"A comprehensive dataset of lipid nanoparticle compositions and properties for nucleic acid delivery","volume":"13","author":"Song","year":"2025","journal-title":"Sci Data"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01036_bib77","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/0126673878324536240805060143","article-title":"Polymeric vehicles for nucleic acid delivery: enhancing the therapeutic efficacy and cellular uptake","volume":"18","author":"Gupta","year":"2024","journal-title":"Recent Adv Drug Deliv Formul"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01036_bib78","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/acschembio.5c00039","article-title":"Optimizing peptide-conjugated lipid nanoparticles for efficient siRNA delivery across the blood-brain barrier and treatment of glioblastoma multiforme","volume":"20","author":"Tong","year":"2025","journal-title":"ACS Chem Biol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01036_bib79","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug Chem"},{"issue":"31","key":"10.1016\/j.neurot.2026.e01036_bib80","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.vaccine.2023.06.009","article-title":"Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: evidence for immunogenicity of PEG","volume":"41","author":"Kozma","year":"2023","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01036_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.111","article-title":"CRISPR delivery with extracellular vesicles: promises and challenges","volume":"2","author":"Berggreen","year":"2023","journal-title":"J Extracell Biol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib82","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0271678X251348816","article-title":"Engineering small extracellular vesicles: unlocking the brain\u2019s secret passage for central nervous system therapies","volume":"46","author":"Zhou","year":"2026","journal-title":"J Cereb Blood Flow Metab"},{"issue":"23","key":"10.1016\/j.neurot.2026.e01036_bib83","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.260201","article-title":"Extracellular vesicles and nanoparticles at a glance","volume":"137","author":"Jeppesen","year":"2024","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41698-024-00600-2","article-title":"Extracellular vesicles in glioblastoma: a challenge and an opportunity","volume":"8","author":"Indira Chandran","year":"2024","journal-title":"npj Precis Oncol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11033-023-09196-5","article-title":"Tumor-derived extracellular vesicles: how they mediate glioma immunosuppression","volume":"51","author":"Ma","year":"2024","journal-title":"Mol Biol Rep"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01036_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12085","article-title":"Biodistribution of extracellular vesicles following administration into animals: a systematic review","volume":"10","author":"Kang","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.neurot.2026.e01036_bib87","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.neurot.2026.e01036_bib88","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2014.12.013","article-title":"Biodistribution and delivery efficiency of unmodified tumor-derived exosomes","volume":"199","author":"Smyth","year":"2015","journal-title":"J Contr Release"},{"key":"10.1016\/j.neurot.2026.e01036_bib89","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.addr.2021.03.017","article-title":"Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design","volume":"173","author":"Kooijmans","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.neurot.2026.e01036_bib90","first-page":"80","article-title":"Isolation and analysis methods of extracellular vesicles (EVs)","volume":"2","author":"Zhao","year":"2021","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12305","article-title":"Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases","volume":"12","author":"Li","year":"2023","journal-title":"J Extracell Vesicles"},{"issue":"17","key":"10.1016\/j.neurot.2026.e01036_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713247","article-title":"Strategies for engineering of extracellular vesicles","volume":"24","author":"Danilushkina","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01036_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102838","article-title":"Surface-engineered extracellular vesicles in cancer immunotherapy","volume":"15","author":"Johnson","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01036_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12130","article-title":"Quantification of protein cargo loading into engineered extracellular vesicles at single-vesicle and single-molecule resolution","volume":"10","author":"Silva","year":"2021","journal-title":"J Extracell Vesicles"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01036_bib95","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1039\/C7NR06966A","article-title":"Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach","volume":"10","author":"Kooijmans","year":"2018","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib96","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1265291","article-title":"TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy","volume":"6","author":"Yuan","year":"2017","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72122-3","article-title":"Extracellular vesicles produced by immunomodulatory cells harboring OX40 ligand and 4-1BB ligand enhance antitumor immunity","volume":"10","author":"Semionatto","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01036_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081848","article-title":"Extracellular vesicles as biological shuttles for targeted therapies","volume":"20","author":"Raimondo","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01036_bib99","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.celrep.2020.01.073","article-title":"Glioma-derived miRNA-Containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells","volume":"30","author":"Lucero","year":"2020","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2013.02.019","article-title":"Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth","volume":"335","author":"Katakowski","year":"2013","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01036_bib101","article-title":"Delivery of functional Anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity","volume":"2","author":"Munoz","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/mt.2012.180","article-title":"Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells","volume":"21","author":"Ohno","year":"2013","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01036_bib103","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1158\/0008-5472.CAN-13-2650","article-title":"Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1","volume":"74","author":"Bronisz","year":"2014","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01036_bib104","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41590-021-00899-0","article-title":"Extracellular vesicles in immunomodulation and tumor progression","volume":"22","author":"Marar","year":"2021","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01036_bib105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s11060-011-0537-1","article-title":"Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma","volume":"104","author":"Bu","year":"2011","journal-title":"J Neuro Oncol"},{"issue":"13","key":"10.1016\/j.neurot.2026.e01036_bib106","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1158\/0008-5472.CAN-12-3918","article-title":"Synergistic induction of adaptive antitumor immunity by codelivery of antigen with alpha-galactosylceramide on exosomes","volume":"73","author":"Gehrmann","year":"2013","journal-title":"Cancer Res"},{"issue":"9329","key":"10.1016\/j.neurot.2026.e01036_bib107","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(02)09552-1","article-title":"Malignant effusions and immunogenic tumour-derived exosomes","volume":"360","author":"Andre","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01036_bib108","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/85438","article-title":"Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming","volume":"7","author":"Wolfers","year":"2001","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib109","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3892\/mmr.2013.1759","article-title":"More efficient induction of antitumor T cell immunity by exosomes from CD40L gene-modified lung tumor cells","volume":"9","author":"Wang","year":"2014","journal-title":"Mol Med Rep"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01036_bib110","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3892\/mmr.2013.1738","article-title":"Exosomes derived from Rab27a-overexpressing tumor cells elicit efficient induction of antitumor immunity","volume":"8","author":"Li","year":"2013","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib111","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2021.04.036","article-title":"Tumor-secreted extracellular vesicles regulate T-Cell costimulation and can be manipulated to induce tumor-specific T-Cell responses","volume":"161","author":"Zhao","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neurot.2026.e01036_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.711565","article-title":"Exosome-based vaccines: history, current state, and clinical trials","volume":"12","author":"Santos","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01036_bib113","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/mt.2008.1","article-title":"Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer","volume":"16","author":"Dai","year":"2008","journal-title":"Mol Ther"},{"issue":"474","key":"10.1016\/j.neurot.2026.e01036_bib114","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat5690","article-title":"Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion","volume":"11","author":"Guo","year":"2019","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01036_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12385","article-title":"MIBlood-EV: minimal information to enhance the quality and reproducibility of blood extracellular vesicle research","volume":"12","author":"Lucien","year":"2023","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib116","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12575-024-00243-4","article-title":"Comparing the proteomic profiles of extracellular vesicles isolated using different methods from long-term stored plasma samples","volume":"26","author":"Torres","year":"2024","journal-title":"Biol Proced Online"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01036_bib117","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70008","article-title":"Separation of small extracellular vesicles (sEV) from human blood by Superose 6 size exclusion chromatography","volume":"13","author":"Nouvel","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.neurot.2026.e01036_bib118","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-99-1443-2_1","article-title":"Updated methods of extracellular vesicles isolation","volume":"1418","author":"Wang","year":"2023","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01036_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/life12111942","article-title":"Comparison of different isolation methods for plasma-derived extracellular vesicles in patients with hyperlipidemia","volume":"12","author":"Zhen","year":"2022","journal-title":"Life"},{"issue":"16","key":"10.1016\/j.neurot.2026.e01036_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17162700","article-title":"The quest for non-invasive diagnosis: a review of liquid biopsy in glioblastoma","volume":"17","author":"Elias","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"23","key":"10.1016\/j.neurot.2026.e01036_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311686","article-title":"Plasma extracellular vesicles as liquid biopsies for glioblastoma: biomarkers, subpopulation enrichment, and clinical translation","volume":"26","author":"Aibaidula","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01036_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.100","article-title":"Optimization of extracellular vesicle isolation and their separation from lipoproteins by size exclusion chromatography","volume":"2","author":"Benayas","year":"2023","journal-title":"J Extracell Biol"},{"key":"10.1016\/j.neurot.2026.e01036_bib123","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/978-1-0716-4406-5_40","article-title":"A size-exclusion chromatography-based procedure for isolating extracellular vesicle subsets from porcine seminal plasma","volume":"2897","author":"Martinez-Diaz","year":"2025","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.neurot.2026.e01036_bib124","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.92796.3","article-title":"Isolation of small extracellular vesicles from small volumes of blood plasma using size exclusion chromatography and density gradient ultracentrifugation","volume":"13","author":"Kong","year":"2026","journal-title":"eLife"},{"issue":"48","key":"10.1016\/j.neurot.2026.e01036_bib125","doi-asserted-by":"crossref","first-page":"65863","DOI":"10.1021\/acsami.4c14542","article-title":"Advanced enrichment and separation of extracellular vesicles through the super absorbent polymer nanosieves","volume":"16","author":"Ham","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.neurot.2026.e01036_bib126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-0716-3850-7_4","article-title":"Isolation of extracellular vesicles from cell culture and blood through nano-targeted DLD microfluidic device","volume":"2804","author":"Gaillard","year":"2024","journal-title":"Methods Mol Biol"},{"issue":"49","key":"10.1016\/j.neurot.2026.e01036_bib127","doi-asserted-by":"crossref","first-page":"25772","DOI":"10.1021\/acs.langmuir.4c02098","article-title":"Microfluidic dielectrophoretic purification of extracellular vesicles from plasma lipoproteins","volume":"40","author":"Sabate Del Rio","year":"2024","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1227\/neu.0000000000002393","article-title":"Advancements and technical considerations for extracellular vesicle isolation and biomarker identification in glioblastoma","volume":"93","author":"Cumba Garcia","year":"2023","journal-title":"Neurosurgery"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01036_bib129","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01036_bib130","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s11095-022-03420-w","article-title":"Enhancing the cellular production of extracellular vesicles for developing therapeutic applications","volume":"40","author":"Erwin","year":"2023","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020663","article-title":"Production and utility of extracellular vesicles with 3D culture methods","volume":"15","author":"Casajuana Ester","year":"2023","journal-title":"Pharmaceutics"},{"issue":"18","key":"10.1016\/j.neurot.2026.e01036_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810522","article-title":"Methods of the large-scale production of extracellular vesicles","volume":"23","author":"Syromiatnikova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2026.e01036_bib133","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jconrel.2021.07.004","article-title":"Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: a head-to-head comparison","volume":"336","author":"Wu","year":"2021","journal-title":"J Contr Release"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib134","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1021\/acsnano.0c09873","article-title":"Selection of fluorescent, bioluminescent, and radioactive tracers to accurately reflect extracellular vesicle biodistribution in vivo","volume":"15","author":"Lazaro-Ibanez","year":"2021","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01036_bib136","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01036_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11071225","article-title":"Potential neurotoxic effects of glioblastoma-derived exosomes in primary cultures of cerebellar neurons via oxidant stress and glutathione depletion","volume":"11","author":"Genc","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.neurot.2026.e01036_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.984690","article-title":"The multiple faces of extracellular vesicles released by microglia: where are we 10 years after?","volume":"16","author":"Gabrielli","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.neurot.2026.e01036_bib139","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.30087","article-title":"Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper","volume":"4","author":"Lener","year":"2015","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-3-10","article-title":"Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial","volume":"3","author":"Escudier","year":"2005","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib141","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1038\/s41467-025-63718-2","article-title":"Engineered exosomes with Kras(G12D) specific siRNA in pancreatic cancer: a phase I study with immunological correlates","volume":"16","author":"Kalluri","year":"2025","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01036_bib142","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2023-101143","article-title":"Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer\u2019s disease: a phase I\/II clinical trial","volume":"36","author":"Xie","year":"2023","journal-title":"Gen Psychiatry"},{"key":"10.1016\/j.neurot.2026.e01036_bib143","series-title":"Public safety notification on exosome products","year":"2019"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib144","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2024051822","article-title":"Polymeric nanoparticles revolutionizing brain cancer therapy: a comprehensive review of strategies and advances","volume":"42","author":"Wahengbam","year":"2025","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.neurot.2026.e01036_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.09.004","article-title":"Construction and application of adenoviral vectors","volume":"34","author":"Zhang","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01036_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/v14122727","article-title":"Significance of preexisting vector immunity and activation of innate responses for adenoviral vector-based therapy","volume":"14","author":"Wang","year":"2022","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01036_bib147","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ymthe.2024.01.035","article-title":"Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice","volume":"32","author":"Shin","year":"2024","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01036_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065910","article-title":"Glioblastoma-derived small extracellular vesicles: nanoparticles for glioma treatment","volume":"24","author":"Araujo-Abad","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01036_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.117","article-title":"Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth","volume":"8","author":"Fareh","year":"2017","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib150","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41467-019-08390-z","article-title":"The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma","volume":"10","author":"Bhaskaran","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2026.e01036_bib151","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2018.08.004","article-title":"Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma","volume":"436","author":"Zeng","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.neurot.2026.e01036_bib152","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.omto.2020.12.006","article-title":"Tumor-derived exosomal microRNA-7-5p enhanced by verbascoside inhibits biological behaviors of glioblastoma in vitro and in vivo","volume":"20","author":"Wang","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.neurot.2026.e01036_bib153","first-page":"204","article-title":"Eliminating the original cargos of glioblastoma cell-derived small extracellular vesicles for efficient drug delivery to glioblastoma with improved biosafety","volume":"16","author":"Guo","year":"2022","journal-title":"Bioact Mater"},{"key":"10.1016\/j.neurot.2026.e01036_bib154","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.2147\/IJN.S263956","article-title":"Inhibition of glioma cells\u2019 proliferation by doxorubicin-loaded exosomes via microfluidics","volume":"15","author":"Thakur","year":"2020","journal-title":"Int J Nanomed"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01036_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051002","article-title":"Glioblastoma-derived exosomes as nanopharmaceutics for improved glioma treatment","volume":"14","author":"Lee","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neurot.2026.e01036_bib156","article-title":"Jingxin Mo Zinc sulfide-based hybrid exosome-coated nanoplatform for targeted treatment of glioblastoma in an orthotopic mouse glioblastoma model","volume":"17","author":"Wenxu Liu","year":"2023","journal-title":"Mater Today Adv"},{"key":"10.1016\/j.neurot.2026.e01036_bib157","article-title":"Ginsenoside Rg3-engineered exosomes as effective delivery platform for potentiated chemotherapy and photoimmunotherapy of glioblastoma","volume":"471","author":"Jinge","year":"2023","journal-title":"Chem Eng J"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib158","article-title":"Engineered brain-targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma","volume":"5","author":"Yang","year":"2025","journal-title":"Explorations"},{"issue":"12","key":"10.1016\/j.neurot.2026.e01036_bib159","doi-asserted-by":"crossref","first-page":"13283","DOI":"10.1007\/s12274-023-5921-6","article-title":"Glioblastoma cell-derived exosomes functionalized with peptides as efficient nanocarriers for synergistic chemotherapy of glioblastoma with improved biosafety","volume":"16","author":"Zhou","year":"2023","journal-title":"Nano Res"},{"key":"10.1016\/j.neurot.2026.e01036_bib160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2017.09.022","article-title":"Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma","volume":"411","author":"Liu","year":"2017","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01036_bib161","doi-asserted-by":"crossref","first-page":"346","DOI":"10.18632\/oncotarget.868","article-title":"Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal","volume":"4","author":"Lee","year":"2013","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01036_bib162","doi-asserted-by":"crossref","first-page":"9911","DOI":"10.18632\/aging.202747","article-title":"Exosomes derived from microRNA-512-5p-transfected bone mesenchymal stem cells inhibit glioblastoma progression by targeting JAG1","volume":"13","author":"Yan","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"15","key":"10.1016\/j.neurot.2026.e01036_bib163","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.18632\/aging.102092","article-title":"Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2","volume":"11","author":"Yu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neurot.2026.e01036_bib164","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2019.11.009","article-title":"Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes","volume":"317","author":"Kim","year":"2020","journal-title":"J Contr Release"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/mt.2011.222","article-title":"Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal Region to the brain","volume":"20","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.neurot.2026.e01036_bib166","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3389\/fonc.2019.00782","article-title":"Potential therapeutic effects of exosomes packed with a miR-21-Sponge construct in a rat model of glioblastoma","volume":"9","author":"Monfared","year":"2019","journal-title":"Front Oncol"},{"issue":"21","key":"10.1016\/j.neurot.2026.e01036_bib167","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.1c07872","article-title":"Correction to \u201cUltrasound Facilitates Naturally Equipped Exosomes Derived from Macrophages and Blood Serum for Orthotopic Glioma Treatment\u201d","volume":"13","author":"Bai","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01036_bib168","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0598-594","article-title":"Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes","volume":"4","author":"Zitvogel","year":"1998","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01036_bib169","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.4161\/onci.20897","article-title":"Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands","volume":"1","author":"Munich","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.neurot.2026.e01036_bib170","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biomaterials.2018.06.029","article-title":"NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo","volume":"178","author":"Jia","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.neurot.2026.e01036_bib171","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2023.11.033","article-title":"Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma","volume":"365","author":"Wang","year":"2024","journal-title":"J Contr Release"},{"issue":"17","key":"10.1016\/j.neurot.2026.e01036_bib172","article-title":"Synchronous disintegration of ferroptosis defense axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01036_bib173","article-title":"Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy","volume":"6","author":"Zhu","year":"2019","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.neurot.2026.e01036_bib174","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jconrel.2022.03.036","article-title":"Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy","volume":"345","author":"Rehman","year":"2022","journal-title":"J Contr Release"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01036_bib175","doi-asserted-by":"crossref","first-page":"497","DOI":"10.20517\/evcna.2024.34","article-title":"Choice of size-exclusion chromatography column affects recovery, purity, and miRNA cargo analysis of extracellular vesicles from human plasma","volume":"5","author":"Bracht","year":"2024","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"10.1016\/j.neurot.2026.e01036_bib176","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.27378","article-title":"Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals","volume":"4","author":"de Menezes-Neto","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.neurot.2026.e01036_bib177","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3389\/fphys.2018.01479","article-title":"Isolation of high-purity extracellular vesicles by the combination of iodixanol density gradient ultracentrifugation and bind-elute chromatography from blood plasma","volume":"9","author":"Onodi","year":"2018","journal-title":"Front Physiol"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01036_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094311","article-title":"Multiple-cycle polymeric extracellular vesicle precipitation and its evaluation by targeted mass spectrometry","volume":"22","author":"Park","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01036_bib179","doi-asserted-by":"crossref","DOI":"10.1093\/biomethods\/bpae032","article-title":"High-throughput surface epitope immunoaffinity isolation of extracellular vesicles and downstream analysis","volume":"9","author":"Khanabdali","year":"2024","journal-title":"Biol Methods Protoc"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01036_bib180","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1039\/C9LC01190K","article-title":"Microfluidic device for high-throughput affinity-based isolation of extracellular vesicles","volume":"20","author":"Lo","year":"2020","journal-title":"Lab Chip"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:52:39Z","timestamp":1792720359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926002060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":180,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1878747926002060"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01036","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles: Navigating new frontiers in glioblastoma therapy","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e01036"}}